ArticleOpen heart2020

Real-world treatment switching to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: A cohort study.

Sashiananthan Ganesananthan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.